Case report demonstrates successful transcatheter patent ductus venosus closure with a Konar-MFO occluder in an infant, indicating a safe minimally invasive approach for congenital shunts.
INTRODUCTION: Congenital portosystemic shunts (CPSS) are rare vascular anomalies that can lead to hyperammonemia and liver dysfunction. CASE PRESENTATION: A 1-month-old infant was diagnosed with incidental patent ductus venosus (PDV) and a focal nodular hyperplasia-like liver nodule. Laboratory tests revealed hyperammonemia (192 µmol/L) and cholestasis. Imaging confirmed a 7.8-mm shunt connecting the left portal vein to the inferior vena cava. Urgent transcatheter closure was performed via the right jugular vein using a 12/10-mm LifeTech™ Konar-MFO occluder. Post-procedural imaging showed complete shunt occlusion, and ammonia levels rapidly decreased to 71.8 µmol/L. Cholestasis improved, and the patient was discharged without complications. CONCLUSION: This report describes the first global use of the Konar-MFO device for PDV closure. Transcatheter embolization using this device is a safe and effective minimally invasive treatment for symptomatic PDV in young infants.
No takes yet. Share an insight, caveat, or question.
Yun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: